Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P50747: Variant p.Gly581Ser

Biotin--protein ligase
Gene: HLCS
Feedback?
Variant information Variant position: help 581 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Glycine (G) to Serine (S) at position 581 (G581S, p.Gly581Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In HLCS deficiency; <10% activity. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 581 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 726 The length of the canonical sequence.
Location on the sequence: help DINLRVKWPNDIYYSDLMKI G GVLVNSTLMGETFYILIGCG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         DINLRVKWPNDIY-----------------------------YSDLMKIGGVLVNSTLMGETFYILIGCG

Mouse                         DINLRVKWPNDIY----------------------------

Baker's yeast                 DIPVRIKWPNDLYALSPTYYKRKNLKLVNTGFEHTKLPLGD

Fission yeast                 NIPAFIKWPNDVY-----------VRVDKGGINFQ------

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 726 Biotin--protein ligase
Domain 463 – 652 BPL/LPL catalytic



Literature citations
Structure of human holocarboxylase synthetase gene and mutation spectrum of holocarboxylase synthetase deficiency.
Yang X.; Aoki Y.; Li X.; Sakamoto O.; Hiratsuka M.; Kure S.; Taheri S.; Christensen E.; Inui K.; Kubota M.; Ohira M.; Ohki M.; Kudoh J.; Kawasaki K.; Shibuya K.; Shintani A.; Asakawa S.; Minoshima S.; Shimizu N.; Narisawa K.; Matsubara Y.; Suzuki Y.;
Hum. Genet. 109:526-534(2001)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS HLCS DEFICIENCY ASP-42; PRO-237; GLU-333; SER-360; CYS-456; SER-470; TRP-508; GLY-547; MET-550; SER-581; THR-610 DEL AND TYR-634; CHARACTERIZATION OF VARIANTS HLCS DEFICIENCY ASP-42; SER-360; CYS-456; SER-470; GLY-547 AND TYR-634; Identification and characterization of mutations in patients with holocarboxylase synthetase deficiency.
Aoki Y.; Li X.; Sakamoto O.; Hiratsuka M.; Akaishi H.; Xu L.; Briones P.; Suormala T.; Baumgartner E.R.; Suzuki Y.; Narisawa K.;
Hum. Genet. 104:143-148(1999)
Cited for: VARIANTS HLCS DEFICIENCY GLU-333; ILE-462; ASN-571; SER-581 AND THR-610 DEL; Relationship between kinetic properties of mutant enzyme and biochemical and clinical responsiveness to biotin in holocarboxylase synthetase deficiency.
Sakamoto O.; Suzuki Y.; Li X.; Aoki Y.; Hiratsuka M.; Suormala T.; Baumgartner E.R.; Gibson K.M.; Narisawa K.;
Pediatr. Res. 46:671-676(1999)
Cited for: VARIANTS HLCS DEFICIENCY PRO-183; ARG-216; PRO-237; GLU-333; ASP-363; SER-581 AND THR-610 DEL; CHARACTERIZATION OF VARIANTS HLCS DEFICIENCY PRO-183; ARG-216; PRO-237; GLU-333; ASP-363; SER-581 AND THR-610 DEL; FUNCTION; CATALYTIC ACTIVITY; BIOPHYSICOCHEMICAL PROPERTIES; Clinical findings and biochemical and molecular analysis of four patients with holocarboxylase synthetase deficiency.
Morrone A.; Malvagia S.; Donati M.A.; Funghini S.; Ciani F.; Pela I.; Boneh A.; Peters H.; Pasquini E.; Zammarchi E.;
Am. J. Med. Genet. 111:10-18(2002)
Cited for: VARIANTS HLCS DEFICIENCY ARG-216; LYS-511; SER-581 AND ARG-582;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.